...
首页> 外文期刊>BMC Psychiatry >Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression (“RAD”) project
【24h】

Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression (“RAD”) project

机译:建立针对焦虑和情绪障碍的临床转化神经科学分类法:基线跟进研究领域的协议焦虑与抑郁(“ RAD”)项目

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Understanding how brain circuit dysfunctions relate to specific symptoms offers promise for developing a brain-based taxonomy for classifying psychopathology, identifying targets for mechanistic studies and ultimately for guiding treatment choice. The goal of the Research Domain Criteria (RDoC) initiative of the National Institute of Mental Health is to accelerate the development of such neurobiological models of mental disorder independent of traditional diagnostic criteria. In our RDoC Anxiety and Depression (“RAD”) project we focus trans-diagnostically on the spectrum of depression and anxiety psychopathology. Our aims are a) to use brain imaging to define cohesive dimensions defined by dysfunction of circuits involved in reactivity to and regulation of negatively valenced emotional stimulation and in cognitive control, b) to assess the relationships between these dimension and specific symptoms, behavioral performance and the real world capacity to function socially and at work and c) to assess the stability of brain-symptom-behavior-function relationships over time. Methods and design Here we present the protocol for the “RAD” project, one of the first RDoC studies to use brain circuit functioning to define new dimensions of psychopathology. The RAD project follows baseline-follow up design. In line with RDoC principles we use a strategy for recruiting all clients who “walk through the door” of a large community mental health clinic as well as the surrounding community. The clinic attends to a broad spectrum of anxiety and mood-related symptoms. Participants are unmedicated and studied at baseline using a standardized battery of functional brain imaging, structural brain imaging and behavioral probes that assay constructs of threat reactivity, threat regulation and cognitive control. The battery also includes self-report measures of anxiety and mood symptoms, and social and occupational functioning. After baseline assessments, therapists in the clinic apply treatment planning as usual. Follow-up assessments are undertaken at 3?months, to establish the reliability of brain–based subgroups over time and to assess whether these subgroups predict real–world functional capacity over time. First enrollment was August 2013, and is ongoing. Discussion This project is designed to advance knowledge toward a neural circuit taxonomy for mental disorder. Data will be shared via the RDoC database for dissemination to the scientific community. The clinical translational neuroscience goals of the project are to develop brain-behavior profile reports for each individual participant and to refine these reports with therapist feedback. Reporting of results is expected from December 2016 onward. Trial registration ClinicalTrials.gov Identifier: NCT02220309 . Registered: August 13, 2014.
机译:背景技术了解脑回路功能障碍如何与特定症状相关联,为开发基于脑的分类法以对心理病理学进行分类,确定机制研究的目标并最终指导治疗选择提供了希望。美国国立精神卫生研究所的研究领域标准(RDoC)计划的目标是促进独立于传统诊断标准的这种精神障碍神经生物学模型的开发。在我们的RDoC焦虑和抑郁(“ RAD”)项目中,我们跨诊断重点关注抑郁和焦虑心理病理学的范围。我们的目标是:a)利用大脑成像来定义由与负价情绪刺激的反应和调节以及认知控制相关的电路功能障碍所定义的内聚维度,b)评估这些维度与特定症状,行为表现和现实世界中社交和工作的能力,以及c)评估大脑症状行为功能关系随时间推移的稳定性。方法和设计在这里,我们介绍“ RAD”项目的协议,这是最早的RDoC研究之一,该研究使用脑回路功能来定义心理病理学的新维度。 RAD项目遵循基线跟踪设计。根据RDoC原则,我们使用一种策略来招募所有在大型社区心理健康诊所以及周边社区“走过大门”的客户。诊所会出现广泛的焦虑和情绪相关症状。参与者没有药物治疗,并且使用功能性脑成像,结构性脑成像和行为探针的标准化电池组进行基线研究,该探针可检测威胁反应性,威胁调节和认知控制的结构。该电池还包括对焦虑和情绪症状以及社会和职业功能的自我报告。经过基线评估后,诊所的治疗师照常应用治疗计划。在3个月时进行随访评估,以建立基于脑的亚组随时间推移的可靠性,并评估这些亚组是否随时间预测现实世界的功能能力。首次注册是2013年8月,并且正在进行中。讨论该项目旨在将知识扩展到针对精神障碍的神经回路分类法。数据将通过RDoC数据库共享,以传播给科学界。该项目的临床翻译神经科学目标是为每位参与者制定大脑行为档案报告,并利用治疗师的反馈意见完善这些报告。预计将从2016年12月开始报告结果。试用注册ClinicalTrials.gov标识符:NCT02220309。注册日期:2014年8月13日。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号